Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female and have been diagnosed with advanced breast cancer (either locally advanced or spread to other parts of the body), confirmed through a biopsy and lab testing as "triple-negative" type.
- People who are planned to receive a specific chemotherapy program consisting of 8 cycles of AC-T chemotherapy.
- People who are older than 18 years of age.
- People who are willing to take part in the research and have signed a consent form agreeing to participate.
Who may not be able to join:
- People who are currently pregnant or breastfeeding.
- People who have already received chemotherapy or are currently taking a medication called simvastatin.
- People who have a known allergy to statins (a type of medication commonly used to manage cholesterol).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Erwin D Yulian, MD, Surgical Oncology Division, Department of Surgery, Universitas Indonesia
Phone: +6281315249627
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Vimentin Expression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.